AI-driven drug discovery’s rapid progression to human trials could revolutionize biotech timelines, potentially accelerating medical advancements.
The post Absci Corporation progresses ABS-201 into human trials, bolstering AI-driven drug discovery appeared first on Crypto Briefing.